The Community Access National Network (CANN) — in collaboration with HealthHIV, HealthHCV, and the National Coalition for LGBT Health — is hosting the 8th Annual National Monitoring Report on HIV/HCV Co-Infection. CANN will present its annual report on the state of co-infection in the United States, including a summary of the HIV/HCV Co-Infection Watch. HealthHCV will present data and implications from ongoing national trends, as shared by patients and providers.


  • Identify the latest data, information, and trends on people co-infected with HIV and hepatitis C (HCV);
  • Describe current access to care and treatment within certain public assistance programs, such as ADAP and Medicaid;
  • Initiate dialogue and strategy to attain more funding for ADAP to treat co-infected clients, particularly ADAP "wrap around" capabilities for insured clients;
  • Summarize the state of HCV prevention and care services in HIV and primary care settings and their implications on ending the HCV epidemic; and,
  • Foster greater collaboration among public health professionals working to combat the dual epidemics of HIV and HCV.

Thiis event is sponsored by ADAP Advocacy, Gilead Sciences, Janssen Pharmaceutical Companies of Johnson & Johnson, and Merck. For more information, please email


8th Annual Monitoring Report on HIV/HCV Co-Infection

  • Wednesday Oct 18 2023, 2:00 PM - 3:30 PM
  • Virtual Report
    United States